Biotechnology is the latest, the newest and the next predicted Huntsville boom. Ever since the day Huntsville became known as the "rocket city," the influx of science, engineering, research, mathematicians, and computer scientists into the area has made the town a magnet for leaders and developers in all things technological.
Today, Cummings Research Park is second only to the Silicon Valley as a world-class research center and it keeps growing. There are currently over 90 biotechnology firms in the state, and at least a dozen of those are in the North Alabama area.
Huntsville's growing biotechnology community includes:
Applied Genomics -- develops targeted diagnostics to improve treatment for cancer patients.
Expression Genetics -- EGEN, Inc., is an Alabama-based specialty biopharmaceutical company developing safe and efficient synthetic biocompatible delivery systems to be used to create products for treatment of human diseases.
HudsonAlpha -- Jim Hudson opened the doors to HudsonAlpha in 2008. Today, HudsonAlpha is a biotechnological cornerstone. A not-for-profit genomics-based research organization, its directive combines academic research, education, and incubation for applied research companies.
Nektar Therapeutics -- a leading biopharmaceutical company, Nektar has developed a robust pipeline of novel therapeutics based on an advanced polymer conjugate chemistry technology platform.
New Century Pharmaceuticals -- founded in 1996 as a “spin out” of research conducted at NASA, New Century’s mission is "to develop and commercialize technologies and products derived from crystallography research on the biophysical and biochemical mechanisms relating to the binding of ligands to serum proteins, including human serum albumin (HSA) for purposes including the development of safer and more efficacious pharmaceuticals."
Open Biosystems -- Building on the rapid sharing model that is at the core of the Human Genome Project, Open Biosystems collaborates with some of the most innovative life science investigators working today. Their products span Genomics, RNAi and Antibodies.
Operon Biotechnologies, Inc. -- the new global leader for oligos and sequencing, three companies from the Eurofins Scientific Group (MWG Biotech, Operon Biotechnologies, and Medigenomix) have merged to become Eurofins MWG Operon.
Partnership for Biotechnology Research -- an alliance of industrial, academic and government organizations dedicated to creating a productive research and entrepreneurial environment for area biotechnology endeavors through education, consolidated business resources and networking opportunities.
SourceCF -- a specialty pharmaceutical and medical company dedicated to cystic fibrosis, the healthcare providers committed to treating the disease, and the research organizations who are developing new and innovative treatments.